Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 2Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 55Leukemia, Myeloid, Acute 38Breast Neoplasms 38Lymphoma, Large B-Cell, Diffuse 35Multiple Myeloma 31Lymphoma, Non-Hodgkin 29Burkitt Lymphoma 29Lymphoma 27Myelodysplastic Syndromes 25Triple Negative Breast Neoplasms 23Recurrence 23Hematologic Neoplasms 22Lymphoma, B-Cell 21Lymphoma, Follicular 20Melanoma 16Ovarian Neoplasms 15Leukemia, Lymphocytic, Chronic, B-Cell 15Neoplasm Metastasis 14Leukemia 14Hodgkin Disease 13Neoplasms 12Leukemia, Biphenotypic, Acute 12Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 11Pancreatic Neoplasms 11Neuroblastoma 11Leukemia, Myelomonocytic, Chronic 11Lymphoma, Mantle-Cell 10Graft vs Host Disease 10Carcinoma, Non-Small-Cell Lung 10Lymphoma, T-Cell, Peripheral 9

Interventions

Magnetic Resonance Spectroscopy 3aldesleukin 2Paclitaxel 2Nivolumab 2Ifosfamide 2Cisplatin 2Adoptive Transfer 2toripalimab 1pembrolizumab 1niraparib 1lenvatinib 1fludarabine 1enfortumab vedotin 1dostarlimab 1cabozantinib 1Ultrasonography 1Specimen Handling 1Sentinel Lymph Node Biopsy 1Magnetic Resonance Imaging 1Ipilimumab 1Fluorodeoxyglucose F18 1FAPI-46 1Cyclophosphamide 1CTLA-4 Antigen 1CP protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Penile Neoplasms × Cyclophosphamide × Clear all
NCT05952947 2024-02-02

HRYZ-T101 Injection for HPV18 Positive Solid Tumor

HRYZ Biotech Co.

Phase 1 Recruiting
32 enrolled
GastrointestinalGenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Uterine Cervical Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡